These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8057304)

  • 1. Synthesis and pharmacological properties of 11-hydroxy-3-(1',1'-dimethylheptyl)hexahydrocannabinol: a high-affinity cannabinoid agonist.
    Yan G; Yin D; Khanolkar AD; Compton DR; Martin BR; Makriyannis A
    J Med Chem; 1994 Aug; 37(16):2619-22. PubMed ID: 8057304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rational search for the separation of psychoactivity and analgesia in cannabinoids.
    Reggio PH; McGaughey GB; Odear DF; Seltzman HH; Compton DR; Martin BR
    Pharmacol Biochem Behav; 1991 Nov; 40(3):479-86. PubMed ID: 1806940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereochemical effects of 11-OH-delta 8-THC-dimethylheptyl in mice and dogs.
    Little PJ; Compton DR; Mechoulam R; Martin BR
    Pharmacol Biochem Behav; 1989 Mar; 32(3):661-6. PubMed ID: 2544901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 9-Nor-9-hydroxyhexahydrocannabinols. Synthesis, Some behavioral and analgesic properties, and comparison with the tetrahydrocannabinols.
    Wilson RS; May EL
    J Med Chem; 1976 Sep; 19(9):1165-7. PubMed ID: 978681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological potency of R- and S-3'-hydroxy-delta 9-tetrahydrocannabinol: additional structural requirement for cannabinoid activity.
    Martin BR; Kallman MJ; Kaempf GF; Harris LS; Dewey WL; Razdan RK
    Pharmacol Biochem Behav; 1984 Jul; 21(1):61-5. PubMed ID: 6087379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 1',1'-chain substituted hexahydrocannabinols: 9β-hydroxy-3-(1-hexyl-cyclobut-1-yl)-hexahydrocannabinol (AM2389) a highly potent cannabinoid receptor 1 (CB1) agonist.
    Nikas SP; Alapafuja SO; Papanastasiou I; Paronis CA; Shukla VG; Papahatjis DP; Bowman AL; Halikhedkar A; Han X; Makriyannis A
    J Med Chem; 2010 Oct; 53(19):6996-7010. PubMed ID: 20925434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
    Rhee MH; Vogel Z; Barg J; Bayewitch M; Levy R; Hanus L; Breuer A; Mechoulam R
    J Med Chem; 1997 Sep; 40(20):3228-33. PubMed ID: 9379442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
    Little PJ; Compton DR; Johnson MR; Melvin LS; Martin BR
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1046-51. PubMed ID: 2849657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel class of potent tetrahydrocannabinols (THCS): 2'-yne-delta 8- and delta 9-THCS.
    Ryan W; Singer M; Razdan RK; Compton DR; Martin BR
    Life Sci; 1995; 56(23-24):2013-20. PubMed ID: 7776826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacology of the isomeric methylheptyl-delta8-tetrahydrocannabinols.
    Huffman JW; Liddle J; Duncan SG; Yu S; Martin BR; Wiley JL
    Bioorg Med Chem; 1998 Dec; 6(12):2383-96. PubMed ID: 9925296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and Pharmacological Evaluation of Minor Cannabinoids from High-Potency Cannabis sativa.
    Radwan MM; ElSohly MA; El-Alfy AT; Ahmed SA; Slade D; Husni AS; Manly SP; Wilson L; Seale S; Cutler SJ; Ross SA
    J Nat Prod; 2015 Jun; 78(6):1271-6. PubMed ID: 26000707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enantioselective synthesis and pharmacology of 11-hydroxy-(1'S,2'R)-dimethylheptyl-delta 8-THC.
    Liddle J; Huffman JW; Wiley JL; Martin BR
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2223-6. PubMed ID: 9873517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological effects in mice of halogenated cannabinol derivatives.
    Yoshida H; Usami N; Ohishi Y; Watanabe K; Yamamoto I; Yoshimura H
    Chem Pharm Bull (Tokyo); 1995 Feb; 43(2):335-7. PubMed ID: 7728937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal mechanisms of delta 9-tetrahydrocannabinol-induced analgesia.
    Smith PB; Martin BR
    Brain Res; 1992 Apr; 578(1-2):8-12. PubMed ID: 1324767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure--activity studies on tetrahydro- and hexahydrocannabinol derivatives.
    Skinner WA; Rackur G; Uyeno E
    J Pharm Sci; 1979 Mar; 68(3):330-2. PubMed ID: 423121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.
    Compton DR; Rice KC; De Costa BR; Razdan RK; Melvin LS; Johnson MR; Martin BR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):218-26. PubMed ID: 8474008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological evaluation of water soluble cannabinoids and related analogs.
    Compton DR; Martin BR
    Life Sci; 1990; 46(22):1575-85. PubMed ID: 2352451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC.
    Martin BR; Compton DR; Semus SF; Lin S; Marciniak G; Grzybowska J; Charalambous A; Makriyannis A
    Pharmacol Biochem Behav; 1993 Oct; 46(2):295-301. PubMed ID: 8265683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation of the alkyl side chain in delta 8-THC.
    Huffman JW; Lainton JA; Dai D; Jordan RD; Duncan SG
    Life Sci; 1995; 56(23-24):2021-4. PubMed ID: 7776827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.